Fund Holdings — GREAT POINT PARTNERS LLC

Total Portfolio Value:
$380.95M
Total Bought:
$87.63M
Total Sold:
$124.24M
Net Transaction:
-$36.61M
Notable People:
Ronald Marc Panzier
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Vera Therapeutics, Inc.CL A(VERA)600,836808,717+207,881$25.78M$26.11M6.85%+$331.6K
Vor Biopharma Inc.(VOR)1,700,0001,126,910-573,090$31.30M$21.50M5.64%-$9.80M
Amylyx Pharmaceuticals, Inc.(AMLX)700,000700,0000$12.57M$20.37M5.35%+$7.80M
Sagimet Biosciences IncCOM SER A2,029,9331,961,701-68,232$15.69M$19.38M5.09%+$3.69M
Definium Therapeutics, Inc.(DFTX)425,000508,735+83,735$19.99M$19.36M5.08%-$629.5K
Ionis Pharmaceuticals, Inc.(IONS)0420,000+420,000$0$18.75M4.92%+$18.75M
Genmab A/SADS(GMAB)0525,000+525,000$0$18.73M4.92%+$18.73M
Sol-Gel Technologies LtdSHS NEW
SHS NEW
274,363239,159-35,204$20.34M$17.76M4.66%-$2.58M
Zura Bio LtdCL A4,215,9304,077,256-138,674$24.87M$16.96M4.45%-$7.91M
LB Pharmaceuticals Inc(LBRX)317,221410,420+93,199$10.30M$15.75M4.13%+$5.46M
ABIVAX Société AnonymeADS(ABVX)204,314155,000-49,314$27.23M$15.35M4.03%-$11.88M
Annexon Inc3,500,0003,500,0000$19.98M$14.80M3.89%-$5.18M
Belite Bio, IncADS(BLTE)075,000+75,000$0$12.74M3.34%+$12.74M
Eupraxia Pharmaceuticals Inc1,200,0001,200,0000$7.93M$10.92M2.87%+$2.99M
Nektar Therapeutics(NKTR)175,000175,0000$12.22M$10.60M2.78%-$1.62M
MoonLake ImmunotherapeuticsCL A(MLTX)855,813855,8130$16.66M$10.01M2.63%-$6.65M
Climb Bio Inc1,000,000800,000-200,000$13.04M$9.18M2.41%-$3.86M
AbCellera Biologics Inc.(ABCL)0600,000+600,000$0$8.75M2.30%+$8.75M
Neurogene Inc352,180300,000-52,180$11.08M$8.35M2.19%-$2.73M
COMPASS Pathways plcADS(CMPS)0500,000+500,000$0$6.22M1.63%+$6.22M
Jatt Ii Acquisition Corp500,000500,0000$5.68M$5.62M1.48%-$57.5K
Inflarx Nv3,046,5573,046,5570$6.82M$5.48M1.44%-$1.34M
Research Alliance Corp IiiCL A0504,891+504,891$0$5.47M1.44%+$5.47M
Bright Minds Biosciences Inc109,603109,6030$7.69M$5.46M1.43%-$2.23M
Amanat Acquisition CorpCL A500,000500,0000$5.08M$5.34M1.40%+$260.0K
Altimmune Inc1,741,2321,741,2320$5.29M$4.98M1.31%-$313.4K
Jatt Iii Acquisition Corp0450,000+450,000$0$4.96M1.30%+$4.96M
Scynexis Inc944,292944,2920$3.84M$4.66M1.22%+$821.5K
Cullinan Therapeutics Inc300,000300,0000$5.46M$4.61M1.21%-$858.0K
Cybin Inc0320,952+320,952$0$3.94M1.04%+$3.94M
Rezolute Inc951,809951,8090$4.95M$3.94M1.03%-$1.01M
Opus Genetics Inc1,970,187776,881-1,193,306$8.10M$3.76M0.99%-$4.34M
Enliven Therapeutics Inc70,00070,0000$3.55M$3.21M0.84%-$343.7K
Relmada Therapeutics Inc842,106842,1060$5.83M$3.17M0.83%-$2.65M
Dbv Technologies S AADS156,906250,000+93,094$2.57M$2.94M0.77%+$366.7K
Evommune Inc325,000325,0000$4.32M$2.68M0.70%-$1.63M
Contineum Therapeutics IncCL A921,481186,183-735,298$15.10M$2.50M0.66%-$12.60M
Oruka Therapeutics, Inc.(ORKA)183,33024,649-158,681$17.45M$2.05M0.54%-$15.39M
Humacyte Inc3,750,0003,750,0000$2.93M$1.94M0.51%-$985.1K
Rein Therapeutics Inc2,575,0001,663,144-911,856$2.68M$1.34M0.35%-$1.34M
Research Alliance Corp IvCL A0106,396+106,396$0$1.28M0.34%+$1.28M
Alumis Inc856,0610-856,061$24.09M$0—-$24.09M
Immix Biopharma, Inc.(IMMX)1,277,6420-1,277,642$13.17M$0—-$13.17M
Palisade Bio, Inc.(PALI)2,284,8190-2,284,819$4.78M$0—-$4.78M
ProMIS Neurosciences, Inc.(PMN)86,1500-86,150$1.13M$0—-$1.13M
Silence Therapeutics plcADS(SLN)450,0000-450,000$4.94M$0—-$4.94M
Page 1 of 1
GREAT POINT PARTNERS LLC — 13F Holdings — Q3 2026 | TickerTrail